潤欣科技(300493.SZ):在AIOT領域公司規劃增加傳感器芯片、分立器件、存儲芯片等產品線
格隆匯5月9日丨潤欣科技(300493.SZ)於2024年05月09日召開業績説明會,就“公司在AIOT領域的研發投入和未來規劃是什麼?”,公司回覆稱,在AIOT領域公司規劃增加傳感器芯片、分立器件、存儲芯片等產品線,增加晶圓代工分銷和模數混合芯片設計業務,整合中國大陸和台灣帶有特色工藝的晶圓代工廠產能,提供包括EDA綜合工具、晶圓CP測試、傳感器封測、芯片定製設計在內的系列服務,保障在優勢領域的無線芯片、信號調理芯片和MEMS傳感器的本地供應,提升公司主營業務的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.